Express Pharma

Jiangsu Alphamab, 3D Medicines and Glenmark sign license pact for KN035 (Envafolimab)

Glenmark will be responsible for further developing, registering, and commercialising Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America